PAVmed Inc.
PAVM
$0.5757
$0.00971.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -33.92% | 22.15% | 166.27% | 378.63% | 375.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -33.92% | 22.15% | 166.27% | 378.63% | 375.71% |
| Cost of Revenue | -54.08% | -24.64% | -0.40% | 8.37% | 48.56% |
| Gross Profit | 70.08% | 53.54% | 51.80% | 45.74% | 3.87% |
| SG&A Expenses | -33.16% | -25.51% | -17.44% | -21.29% | -28.18% |
| Depreciation & Amortization | -90.09% | -72.33% | -47.35% | -26.42% | -12.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.11% | -33.36% | -23.96% | -25.91% | -29.24% |
| Operating Income | 42.50% | 35.34% | 27.70% | 29.72% | 32.03% |
| Income Before Tax | 186.77% | 135.86% | 111.43% | 23.28% | 28.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 186.77% | 135.86% | 111.43% | 23.28% | 28.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -40.39% | -24.69% | -8.73% | -4.62% | -10.59% |
| Net Income | 220.36% | 162.00% | 134.45% | 26.95% | 31.75% |
| EBIT | 42.50% | 35.34% | 27.70% | 29.72% | 32.03% |
| EBITDA | 40.91% | 34.28% | 27.34% | 30.10% | 32.90% |
| EPS Basic | 173.07% | 129.64% | 105.99% | 34.96% | 38.97% |
| Normalized Basic EPS | 75.29% | 67.60% | 45.65% | 49.04% | 50.42% |
| EPS Diluted | 106.35% | 74.21% | 58.80% | 34.95% | 38.96% |
| Normalized Diluted EPS | 84.61% | 74.02% | 50.37% | 49.04% | 50.42% |
| Average Basic Shares Outstanding | 40.87% | 33.77% | 32.38% | 30.09% | 27.28% |
| Average Diluted Shares Outstanding | 664.62% | 571.90% | 159.57% | 30.09% | 27.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |